← Open Payments lookup

MICHELLE VESS: Open Payments

NPI 1528192697 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$541 in 41 payments from 7 companies in 2025. Trend: 2023 $397 · 2024 $516 · 2025 $541

Food & beverage: $541
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$250
ABBVIE INC.15$138
E.R. Squibb & Sons, L.L.C.3$53
Neurocrine BioSciences, Inc.2$37
Vanda Pharmaceuticals Inc.1$33
Janssen Pharmaceuticals, Inc1$16
Teva Pharmaceuticals USA, Inc.1$14

Products named: CAPLYTA, VRAYLAR, COBENFY, INGREZZA, FANAPT, INVEGA SUSTENNA, UZEDY.

Industry payments across TX — which companies pay providers there.